Clinical Trial Update: A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH) [Phase 2]

View source ↗

Summary

Phase 2 trial update for BMN 111 (vosoritide) evaluating long-term safety, tolerability, and efficacy in children with achondroplasia. The study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• Vosoritide (vosoritide)

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Achondroplasia | Phase 2 | Status: ACTIVE_NOT_RECRUITING